Conference series takes pleasure in inviting the scientific community across the globe to attend the 11^thEuropean Biosimilars Congress duringApril 26-27, 2018atRome, Italywith a motto to Explore Innovations in Biosimilars & Biologics. This European Biosimilars Congress 2018 will bring together Professors, scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials, CROs and students from around the world. The passage of biosimilars through a decade at Europe finds much requirement for discussion also focussing the latest developments in the field of biologics and biosimilars.

Previous Speakers:

Kamali Chance,Quintiles Inc.,, USA; Ruideger Janwosky,Cinfa Biotech GmbH, Germany; Christoph Volpers,Michalski Hüttermann & Partner Germany;Arthur G Cook,ZS Associates USA;Stanley Seung Suh Hong, Celltrion Healthcare Co. Ltd. South Korea;Fiona M Greer, SGS Life Sciences, Switzerland;András Guttman,University of Pannonia,Hungary SCIEX, USA;Ulrike Konrad,Protagen Protein Services , Germany;Tim Demuth,Sandoz Pharmaceuticals GmbH, Germany;Rosa Helena Bustos,University of La Sabana, Colombia;Tsachi Shaked,E3D (Elcam Drug Delivery Devices), Israel;Efraín Esteban,University of La Sabana, Colombia;Ulrich StorzMichalski Hüttermann & Partner, Germany;Andreu Soldevila,CEO LeanBioPro, Spain;Laszlo Endrenyi,University of Toronto, Canada;Raymond A Huml,Quintiles, Inc., USA;Patrick LucyPfenex Inc., USA;

Euro Biosimilars 2018Conference will encourage Young Researcher’s Forum, scientists and the researchers in their early stage of career graph to widely discuss their outcome so as to enrich and develop the idea. The ‘Best Poster Award’ is meant to encourage students in taking active part in the International Science platform to sharpen their skills and knowledgebase.

The important tracks that are part ofEuro Biosimilars 2018includes:

Current Challenges in Developing Biosimilars, Emerging Biosimilars in Therapeutics, Analytical Strategies for Biosimilars, Regulatory Approach of Biosimilars, Biosimilar Companies and Market Analysis, Innovative Approach for Biosimilars, Clinical Development of Biosimilars, Consequences of Brexit on Biosimilars, Intellectual Property Rights, Globalization of Biosimilars, Bioequivalence Assessment, Biosimilars Research Pipeline, BCS and IVIVC Based Biowaivers, Biosimilar Market and Cost Analysis, Challenges in Biosimilars Pharmacovigilance, Legal Issues and BPCI Act, Entrepreneurs Investment Meet

Euro Biosimilars 2018is comprised of 17 tracks and 90 sessions designed to offer comprehensive sessions that address current issue. For more scientific sessions and abstract submission, please visit:

http://biosimilars-biologics.pharmaceuticalconferences.com/europe/

The Abstracts that are accepted for presentations are published in the proceedings of the Journals likeJournal of Bioanalysis & Biomedicine, Journal of Bioequivalence & Bioavailability : Open Access.

Grab the opportunity to participate by registering through flowing link:

http://biosimilars-biologics.pharmaceuticalconferences.com/europe/registration.php

For further details, please contact:
Badoni Victor | Program Director
Biosimilars Conferences
Direct: (702) 508-5200 Ext: 8028
Customer Service: +1 (800) 216 6499
E:eurobiosimilars@pharmaceuticalconferences.org

Read offline:

Related Articles:

	Addressing the Ethnic Disparity in SAT scoresFor high-school students, the SAT is one of the most, if not the most, important assessments of academic achievement. Nevertheless, the SAT is shrouded in controversy, including a persistent and…
	Stimulating nursing students’ interest in community care…Despite increased healthcare extramuralisation, related to increased elderly patients living at home, most nursing students still see the hospital as career favourite. This is problematic, because of the widespread labour-market…
	Fullerene soot nanoparticles impose threat to glial cell…Nanotechnology principally deals with engineering or fine tuning of functional matters at their molecular level. The field has generated an exciting scientific attention globally because of the innumerable possibilities it…
	Developing aptamers and 21st century skills through…Among the growing list of aptamer applications, innovative aptamer Course-Based Undergraduate Research Experiences (CUREs) have merged the scientific demand of aptamers with the positive student outcomes realized through authentic research…
	Strong primary healthcare may reduce mortalityHealthcare is variably organized across the world. In some places, people attend medical specialists such as cardiologists and urologists directly. In other places, people attend primary care physicians for most…
	Bacillus coagulans Unique IS-2 helps ease symptoms of…Irritable bowel syndrome (IBS) is a common disorder that affects the digestive system. It is a mixture of abdominal pain and altered bowel frequency either constipation, diarrhoea or both (mixed).…